Company profile: Astoriom
1.1 - Company Overview
Company description
- Provider of ICH-compliant sample stability and biorepository storage solutions for pharmaceutical and medical device sectors, offering controlled temperature/humidity from -196°C to +60°C with cGMP compliance, packaging and transport; custom storage design; equipment service and validation; disaster protection and recovery; and inventory intelligence with real-time reporting and audit trails.
Products and services
- Sample Storage Biorepository Solutions: Astoriom delivers cGMP-compliant biorepository storage spanning -196°C to +60°C, with packaging and transportation services for pharmaceutical and medical device samples
- Sample Stability Storage Solutions: Astoriom engineers ICH-compliant stability storage with controlled temperature and humidity conditions, tailored to various global climatic zones for pharmaceutical and medical device samples
- Sample Storage Service & Validation Solutions: Astoriom offers regulatory-compliant equipment service and validation to maintain storage systems’ performance and compliance, executed onsite or offsite to enhance operational efficiency
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Astoriom
Perigord
HQ: Ireland
Website
- Description: Provider of best-in-class labeling artwork to life science companies, with unparalleled expertise in highly regulated sectors, and developer of the world’s only dedicated Pharmaceutical Artwork Management System, GLAMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perigord company profile →
Quartesian
HQ: United States
Website
- Description: Provider of biostatistics, programming, and medical writing services, delivering customized, insightful data to organizations performing clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quartesian company profile →
Medpace
HQ: United States
Website
- Description: Provider of clinical development services as a global clinical research organization for pharmaceutical and biotechnology industries, offering integrated clinical trial support including central and bioanalytical laboratories, imaging and ECG core labs, a Phase I unit, CTMS, therapeutic expertise, decentralized trial capabilities, and remote biosensing technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medpace company profile →
Biodextris
HQ: Canada
Website
- Description: Provider of analytical and process development, early-phase clinical manufacturing, packaging, and scalable bioproduction services for vaccines and biologics. Offers quality control testing and validation to ensure regulatory compliance, with tailored development solutions for biotech and pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biodextris company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Astoriom
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Astoriom
2.2 - Growth funds investing in similar companies to Astoriom
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Astoriom
4.2 - Public trading comparable groups for Astoriom
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →